HIV Infections Clinical Trials

129 recruitingLast updated: June 17, 2026

There are 129 actively recruiting hiv infections clinical trials across 44 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4. Top locations include San Francisco, California, United States, New York, New York, United States, Seattle, Washington, United States. Updated daily from ClinicalTrials.gov.


HIV Infections Trials at a Glance

129 actively recruiting trials for hiv infections are listed on ClinicalTrialsFinder across 6 cities in 44 countries. The largest study group is Not Applicable with 59 trials, with the heaviest enrollment activity in San Francisco, New York, and Seattle. Lead sponsors running hiv infections studies include ViiV Healthcare, Columbia University, and University of California, San Francisco.

Browse hiv infections trials by phase

Treatments under study

About HIV Infections Clinical Trials

Looking for clinical trials for HIV Infections? There are currently 129 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 129 trials

Recruiting
Not Applicable

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

HIV InfectionsSubstance Use Disorders
Medical University of South Carolina50 enrolled1 locationNCT05816083
Recruiting
Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled9 locationsNCT06665646
Recruiting

Skeletal Muscle Energetics and Fatiguability in Older Individuals

HIV InfectionsHIV
Johns Hopkins University200 enrolled1 locationNCT04142047
Recruiting
Not Applicable

An Effectiveness Trial of the PrEP for WINGS Study

HIV InfectionsAlcohol Use DisorderViolence, Gender-Based
Columbia University307 enrolled1 locationNCT06853314
Recruiting
Phase 1

Dasatinib for HIV-1 Reservoir Reduction

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)14 enrolled3 locationsNCT07342491
Recruiting
Not Applicable

Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa

HIV InfectionsMental Health
Emory University60 enrolled1 locationNCT07226323
Recruiting
Phase 1Phase 2

The Tatelo Plus Study

HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID)41 enrolled2 locationsNCT06508749
Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

HIV Infections
Gilead Sciences3,000 enrolled17 locationsNCT07473778
Recruiting
Not Applicable

The TAIL-PrEP Study

HIV Infections
Columbia University30 enrolled1 locationNCT06868641
Recruiting

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

HIV Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine2,500 enrolled4 locationsNCT05147519
Recruiting
Not Applicable

An Adaptive Randomized Controlled Trial

HIV InfectionsMulti Drug Resistant Tuberculosis
Columbia University360 enrolled1 locationNCT05633056
Recruiting
Not Applicable

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

HIV InfectionsCervix CancerHPV Infection
UNC Lineberger Comprehensive Cancer Center7,597 enrolled1 locationNCT07428330
Recruiting
Phase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Not Applicable

A Setting Focus Overdose Prevention Intervention

HIV InfectionsHCVDrug Overdose
Johns Hopkins Bloomberg School of Public Health285 enrolled1 locationNCT05320835
Recruiting
Phase 1Phase 2

A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1

HIV Infections
ViiV Healthcare44 enrolled1 locationNCT07275606
Recruiting
Not Applicable

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

HIV InfectionsHIV InfectionAlcohol Use Disorder+2 more
San Diego State University716 enrolled1 locationNCT06771843
Recruiting
Not Applicable

Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness

HIV Infections
The University of Texas Health Science Center, Houston450 enrolled1 locationNCT06074354
Recruiting
Phase 2

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

HIV Infections
ViiV Healthcare150 enrolled113 locationsNCT07202546
Recruiting
Phase 1

Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.

HIV Infections
International AIDS Vaccine Initiative96 enrolled6 locationsNCT06694753
Recruiting
Not Applicable

Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

HIV Infections
Oswaldo Cruz Foundation400 enrolled2 locationsNCT07584122